Downregulation of friend leukemia virus integration 1 as a feedback mechanism that restrains lipopolysaccharide induction of matrix metalloproteases and interleukin-10 in human macrophages

Journal of Interferon and Cytokine Research

Volumn 30, Issue 12, 2010, Pages 893-900

  Ho, Hao H ^a,b   Ivashkiv, Lionel B ^a,c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Weill Cornell Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; STROMELYSIN; STROMELYSIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ESE 3; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR TEL 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEEDBACK SYSTEM; FRIEND LEUKEMIA VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MODULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA INTERFERENCE; STIMULATION; VIRUS DNA CELL DNA INTERACTION;

CELLS, CULTURED; DOWN-REGULATION; FEEDBACK, PHYSIOLOGICAL; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGES; MATRIX METALLOPROTEINASES; PROTO-ONCOGENE PROTEIN C-FLI-1;

FRIEND MURINE LEUKEMIA VIRUS;

EID: 78649997684     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0046     Document Type: Article

References (40)

1. Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. 2000. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia 14(3):439-445.
2. Baillat D, Leprivier G, Regnier D, Vintonenko N, Begue A, Stehelin D, Aumercier M. 2006. Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter. Oncogene 25(42): 5764-5776.
3. Basuyaux JP, Ferreira E, Stehelin D, Buttice G. 1997. The Ets transcription factors interact with each other and with the c- Fos/c-Jun complex via distinct protein domains in a DNAdependent and -independent manner. J. Biol. Chem. 272(42): 26188-26195.
4. Ben David Y, Giddens EB, Letwin K, Bernstein A. 1991. Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5(6): 908-918.
5. Benbow U, Brinckerhoff CE. 1997. The AP-1 site and MMP gene regulation: What is all the fuss about? Matrix Biol 15(8-9):519-526.
6. Bidder M, Loewy AP, Latifi T, Newberry EP, Ferguson G, Willis DM, Towler DA. 2000. Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element. Biochemistry 39(30):8917-8928.
7. Brown LA, Rodaway AR, Schilling TF, Jowett T, Ingham PW, Patient RK, Sharrocks AD. 2000. Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech Dev. 90(2):237-252.
8. Buttice G, Kurkinen M. 1993. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13- acetate response of the human stromelysin gene. J. Biol. Chem. 268(10):7196-7204.
9. Cardone M, Kandilci A, Carella C, Nilsson JA, Brennan JA, Sirma S, Ozbek U, Boyd K, Cleveland JL, Grosveld GC. 2005. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis. Mol Cell Biol 25(6):2395-2405. (Pubitemid 40354633)
10. Carella C, Potter M, Bonten J, Rehg JE, Neale G, Grosveld GC. 2006. The ETS factor TEL2 is a hematopoietic oncoprotein. Blood 107(3):1124-1132.
11. Chakrabarti SR, Sood R, Nandi S, Nucifora G. 2000. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc Natl Acad Sci USA 97(24):13281-13285.
12. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. 2003. Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253(1-2):269-285.
13. Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker- Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW. 2000. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 20(16):5828-5839.
14. Fuchs B, Inwards CY, Janknecht R. 2003. Upregulation of the matrix metalloproteinase-1 gene by the Ewings sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300. FEBS Lett 553(1-2):104-108.
15. Ho HH, Antoniv TT, Ji JD, Ivashkiv LB. 2008. Lipopolysaccharide- induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1. J Immunol 181(7):5089-5097.
16. Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT, Woodgett JR, Ivashkiv LB. 2006. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24(5):563-574.
17. Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K. 2005. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 33(11):3540-3549.
18. Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH. 2005. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer Cell FEBS Lett 579(18):3941-3946.
19. Kas K, Finger E, Grall F, Gu X, Akbarali Y, Boltax J, Weiss A, Oettgen P, Kapeller R, Libermann TA. 2000. ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J. Biol. Chem. 275(4):2986-2998.
20. Klemsz MJ, Maki RA, Papayannopoulou T, Moore J, Hromas R. 1993. Characterization of the ets oncogene family member, fli- 1. J. Biol. Chem. 268(8):5769-5773.
21. Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D. 1983. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306(5941):395-397.
22. Li R, Pei H, Watson DK. 2000. Regulation of Ets function by protein-protein interactions. Oncogene 19(55):6514-6523.
23. Libby P. 2000. Changing concepts of atherogenesis. J Intern Med 247(3):349-358.
24. Nunn MF, Seeburg PH, Moscovici C, Duesberg PH. 1983. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306(5941):391-395.
25. Oikawa T. 2004. ETS transcription factors: Possible targets for cancer therapy. Cancer Sci 95(8):626-633.
26. Oikawa T, Yamada T. 2003. Molecular biology of the Ets family of transcription factors. Gene 303:11-34.
27. Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J. 1999. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 18(8):1597-1608.
28. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Zhang M, McManus MT, Gertler FB, Scott ML, Van Parijs L. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33(3):401-406.
29. Seth A, Robinson L, Thompson DM, Watson DK, Papas TS. 1993. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: Stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Oncogene 8(7):1783-1790.
30. Seth A, Watson DK. 2005. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41(16):2462-2478.
31. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK. 2000. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 20(15): 5643-5652.
32. Stoll G, Bendszus M. 2006. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37(7):1923-1932.
33. Szekanecz Z, Koch AE. 2007. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 19(3):289-295.
34. Takahashi K, Takeya M, Sakashita N. 2002. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 35(4):179-203.
35. Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben David Y. 1999. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 19(6):4452-4464.
36. Truong AH, Ben David Y. 2000. The role of Fli-1 in normal cell function and malignant transformation. Oncogene 19(55): 6482-6489.
37. Tugores A, Le J, Sorokina I, Snijders AJ, Duyao M, Reddy PS, Carlee L, Ronshaugen M, Mushegian A, Watanaskul T, Chu S, Buckler A, Emtage S, McCormick MK. 2001. The epitheliumspecific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades. J. Biol. Chem. 276(23):20397-20406.
38. Unemori EN, Bair MJ, Bauer EA, Amento EP. 1991. Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metallo roteinases by interferongamma. J. Biol. Chem. 266(34):23477-23482.
39. Westermarck J, Seth A, Kahari VM. 1997. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14(22):2651-2660.
40. Zhang L, Eddy A, Teng YT, Fritzler M, Kluppel M, Melet F, Bernstein A. 1995. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol 15(12):6961-6970.